What is the most common cause of asymmetric intrauterine growth restriction (IUGR) in a newborn?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Cause of Asymmetric Intrauterine Growth Restriction

The most common cause of asymmetric IUGR in a newborn is placental insufficiency, which accounts for 25-30% of all fetal growth restriction cases. 1

Understanding Asymmetric vs. Symmetric IUGR

While the traditional classification of IUGR into symmetric and asymmetric patterns was historically thought to provide valuable prognostic information, recent evidence demonstrates that the HC/AC ratio (which defines asymmetric vs. symmetric IUGR) is not an independent predictor of adverse pregnancy outcomes. 1 Growth and developmental outcomes from birth to age 4 years are similar in both symmetric and asymmetric growth-restricted preterm newborns. 1

Despite this limitation in prognostic value, the asymmetric pattern (characterized by "head-sparing" with preserved head circumference relative to abdominal circumference) remains clinically relevant for understanding the underlying etiology.

Primary Etiologic Categories

Placental insufficiency due to suboptimal perfusion of the maternal-placental circulation is the leading cause, responsible for 25-30% of all FGR cases. 1 This is particularly true for:

  • Late-onset FGR (diagnosed ≥32 weeks), which represents 70-80% of all FGR cases and is typically associated with placental underperfusion 1
  • Maternal hypertensive disorders and vascular disease 1
  • Uteroplacental insufficiency with histologic findings of fibrinoid necrosis, villous fibrosis, avascular terminal villi, and villous infarcts 2

Chromosomal disorders and congenital malformations account for approximately 20% of FGR cases. 1 These are more commonly associated with:

  • Early-onset FGR (diagnosed <32 weeks gestation) 1
  • Symmetric growth restriction patterns 1

Clinical Context and Timing

The gestational age at diagnosis provides important etiologic clues:

  • Earlier in gestation: Chromosomal anomalies, syndromes, and viral infections are more common etiologies 1
  • Later in gestation: Placental insufficiency predominates, especially related to hypertension and maternal vascular disease 1

Asymmetric FGR with "head-sparing" is characteristically more common in late-onset cases, where placental insufficiency leads to preferential blood flow redistribution to protect the fetal brain at the expense of abdominal/somatic growth. 1

Important Clinical Pitfall

A critical caveat: approximately 40% of IUGR cases have no identifiable underlying pathology despite thorough evaluation. 3 Among preventable environmental causes, maternal smoking during pregnancy is the single most important modifiable risk factor, responsible for more than one-third of all IUGR newborns. 3

Practical Approach

When evaluating an asymmetric growth-restricted newborn:

  • Placental pathology should be examined for lesions of uteroplacental insufficiency, which show the strongest correlation with asymmetric IUGR 2
  • Maternal history of hypertensive disorders is a key association with late-onset asymmetric FGR 1
  • Detailed fetal structural survey should have been performed prenatally, as approximately 10% of fetuses with FGR have congenital anomalies 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.